$1.2m study to improve patient care for asthma and COPD

A team of clinicians and researchers from the SingHealth Duke-NUS Academic Medical Centre and GlaxoSmithKline (GSK) is conducting a three-year study which aims to create a database for research into respiratory diseases by accelerating the digitisation and integration of records of patients who suffer from asthma and chronic obstructive pulmonary disease (COPD) - a serious disease that limits airflow to the lungs.

• The Straits Times, 18 October 2017, Home, pB5